However, P2X7 knockdown [46] or antagonism [47] reduces leukaemia growth in mice, so the use of a P2X7 antagonist or inhibitory mAb may have a dual role in both preventing GVHD whilst reducing leukaemia in blood cancer patients following alloHSCT. The gene discussed is P2RX7; the disease is leukemia.